Regional citrate anticoagulation for replacement therapy in patients with liver failure: A systematic review and meta-analysis

Regional citrate anticoagulation for replacement therapy in patients with liver failure: A systematic review and meta-analysis

BackgroundCitrate refers to an anticoagulant agent commonly used in extracorporeal organ support. Its application is limited in patients with liver failure (LF) due to the increased risk of citrate accumulation induced by liver metabolic dysfunction. This systematic review aims to assess the efficac...

Full description

Bibliographic Details
Main Authors:	Bo Peng, Jiaqi Lu, Hebing Guo, Jingyuan Liu, Ang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Nutrition
Subjects:	anticoagulation citrate liver failure extracorporeal organ support renal replacement therapy molecular adsorbent recirculation system
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2023.1031796/full

Similar Items

Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis
by: Wei Zhang, et al.
Published: (2019-01-01)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
by: Fang Hu, et al.
Published: (2022-10-01)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
by: Haixia Huang, et al.
Published: (2023-03-01)

Clinical application of regional citrate anticoagulation for membrane-based therapeutic plasma exchange in children with liver failure
by: Jun Hu, et al.
Published: (2023-10-01)

Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
by: Min-min Wang, et al.
Published: (2023-10-01)

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
by: Yuelin Sun, et al.
Published: (2023-06-01)

Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study
by: Ying Yu, et al.
Published: (2018-07-01)

Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study
by: Dan Liu, et al.
Published: (2024-01-01)

Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus
by: Shu-Yuan Liu, et al.
Published: (2023-05-01)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
by: Matthias Klingele, et al.
Published: (2017-11-01)

Complications of regional citrate anticoagulation: accumulation or overload?
by: Antoine G. Schneider, et al.
Published: (2017-11-01)

Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study
by: Christophe Leroy, et al.
Published: (2021-01-01)

Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: Rita Jacobs, et al.
Published: (2023-05-01)

Simple citrate anticoagulation protocol for low flux haemodialysis
by: Eng Kuang Lim, et al.
Published: (2018-01-01)

The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study
by: Richard Fisher, et al.
Published: (2017-10-01)

A Rare Case of Severe Metabolic Alkalosis with Unusual Hyperproteinemia Treated with Continuous Renal Replacement Therapy and Regional Citrate Anticoagulation
by: Vojtěch Matoušek, et al.
Published: (2018-08-01)

Comparison of Citrate and Heparin for Continuous Renal Replacement Therapy in Pediatric Intensive Units
by: Edin Botan, et al.
Published: (2023-12-01)

Construction and validation of a prediction model for the risk of citrate accumulation in patients with hepatic insufficiency receiving continuous renal replacement therapy with citrate anticoagulation
by: Quxia Hong, et al.
Published: (2024-01-01)

Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission
by: Valentina Pistolesi, et al.
Published: (2023-03-01)

Monocytes as Targets for Immunomodulation by Regional Citrate Anticoagulation
by: Giovana Seno Di Marco, et al.
Published: (2024-03-01)

Regional Citrate Anticoagulation and Systemic Anticoagulation during Pediatric Continuous Renal Replacement Therapy: A Systematic Literature Review
by: Emanuele Buccione, et al.
Published: (2022-05-01)

Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure
by: Ramón A. Kobashi-Margáin, et al.
Published: (2011-01-01)

Anticoagulation during continuous renal replacement therapy: An update
by: Aslanidis Theodoros, et al.
Published: (2019-01-01)

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
by: Willem Boer, et al.
Published: (2023-03-01)

Use of regional citrate anticoagulation with medium cut-off membrane: pilot report
by: Marija Malgaj Vrečko, et al.
Published: (2022-10-01)

Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury
by: De-Lin Liu, et al.
Published: (2016-01-01)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
by: Jing Jiao, et al.
Published: (2023-12-01)

Acute liver failure and the molecular adsorbents recirculating system: Early experience in a tertiary care hospital in Mexico City
by: Nahum Mendez-Sanchez, et al.
Published: (2004-10-01)

Extracorporeal blood purification in patients with liver failure: Considerations for the low-and-middle income countries of Latin America
by: Vladimir Barrera Villanueva, et al.
Published: (2023-01-01)

Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy
by: Filippo Mariano, et al.
Published: (2023-09-01)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
by: Ilan Lenga, et al.
Published: (2019-12-01)

Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis
by: Mihai Popescu, et al.
Published: (2023-03-01)

Quality indicators in prolonged hemodialysis with regional citrate anticoagulation with the genius system: retrospective cohort of critical patients with acute kidney injury
by: Jorge Alberto Menegasso Vieira, et al.
Published: (2023-11-01)

Regional citrate anticoagulation “non-shock” protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
by: Lenar Yessayan, et al.
Published: (2021-07-01)

Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
by: Richard Fisher, et al.
Published: (2022-03-01)

Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring
by: Federico Nalesso, et al.
Published: (2023-08-01)

Experience of Treatments of Amanita Phalloides-induced Fulminant Liver Failure with Molecular Adsorbent Recirculating System and Therapeutic Plasma Exchange
by: Chunting Wang, et al.
Published: (2014-12-01)

Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States
by: David Boldt, et al.
Published: (2023-12-01)

Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
by: See Kay, et al.
Published: (2009-01-01)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
by: Andreas Margraf, et al.
Published: (2022-06-01)